Surgical platform UltraGreen targets Asia for growth
Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market
[SINGAPORE] Medical procedures can be risky. One company is providing data that could help reduce complications from surgery.
Now, with Singapore in the centre of its plans, UltraGreen is looking to tap the sizeable Asian market for growth.
The company’s fluorescent dye and artificial intelligence (AI) platform gives surgeons an “inside look” into living tissue, by measuring and monitoring blood flow in the human tissue.
TRENDING NOW
Can a first-time homebuyer couple earning S$18,000 a month afford a new EC unit?
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Asia needs new energy security architecture
Chagee, Mixue and Luckin won the market. Sustaining their edge is the harder part